<img height="1" width="1" src="https://www.facebook.com/tr?id=914352225269004&amp;ev=PageView%20&amp;noscript=1">

Evrima is reimagining the clinical trial management process and delivering better outcomes - for everybody.

Qualified trial participants

You need your clinical trial to commence efficiently. We recruit, screen and on-board a diverse range of right-fit clinical trial participants, at the right time.

Real-time data

You need to know how your clinical trial recruitment and enrollment is progressing in real-time. Evrilink delivers accurate, secure and visible data and reporting solutions.

A better participant experience

Our Patient Experience team, along with Evrima’s tech-enabled workflow processes built into the Evrilink platform, ensure an exceptional experience for all trial participants.

Clinical trial marketing support

Need your clinical trial promoted in the community? Do you have multi-channel marketing campaigns and advertising services within your budget? Our specialist Evrima marketing team can help.

90%

90% of Australian clinical trials are delayed due to recruitment challenges. Let’s reduce that delay, together.

60+

Clinical trials

We’ve supported over 60 clinical trials with recruitment and management services. And that number is growing.

Evrilink Logo Colour_090723
Transparent, efficient clinical trial management. It’s here now.

You can leverage the power of Evrilink for your clinical trial. The purpose-built platform allows you to gain valuable, real-time data relating to your trial - from tech-enabled recruitment to enrollment. Solutions-focused workflows are built-in, delivering a better, more efficient and centralised, clinical trial experience for everybody.

Discover Evrilink
Group 10
Evrilink Logo Colour_090723
Tailored clinical trial recruitment and marketing solutions

Clinical trials aren’t all the same. Evriquest is tailored to your specific clinical trial objectives and targets. From recruitment services to marketing support, our experienced team is ready to partner with you to expedite your clinical trial.

Discover Evriquest
Group 10
Evrilink Logo Colour_090723
Collaborating with GPs for better patient outcomes

We’ve made it easy for GPs to refer their patients for potentially life-changing clinical trials that can lead to improved health outcomes and medical breakthroughs. Evripath is quick, easy and secure for GPs to access. They can search available clinical trials and refer their patients for trial screening.

Discover Evripath
Group 10

FAQs and answers for clinical trial sponsors

01

What global data and cyber security safeguards does Evrima have in place?

-

Evrima has advanced privacy and data protection safeguards built-in. We’re GCP Compliant, CFR Part 11 Compliant, have a robust Privacy Policy and Terms of Service.

02

What types of clinical trials does Evrima support?

+

Evrima’s Evrilink supports phase 1 to 4 clinical trials across many different therapeutic areas. Contact our team to discuss your specific clinical trial support needs, we’re here to help.

03

How do clinical trial sites use Evrilink and when should it be activated?

+

We recommend activating your Evrilink account before recruitment starts. Once we receive the green-light from you and the trial is Ethics approved, the trial can be established in Evrilink and then you can invite your sites and research partners to start recruiting for the trial. If your protocol changes, or new sites are added, these changes can be updated in Evrilink so your team has access to the latest information - in real-time. The power of Evrilink can also be harnessed to streamline and expedite recruitment for trials that are already underway, too. Contact us today to find out more.

Latest news

News

Breaking News: Groundbreaking Australian Pilot Unveils Cutting-Edge Clinical Trial Recruitment Pathw ...
Read More

News

Evrima Technologies Founder and CEO, Charlotte Bradshaw, Wins Entrepreneur/Founder Award at Atlassia ...
Read More

News

Evrima Technologies Excited to Showcase Innovations in Vaccine Trial Recruitment at 2024 World Vacci ...
Read More